These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19200133)

  • 1. Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients.
    Lee JH; Yoon JH; Lee CH; Myung SJ; Keam B; Kim BH; Chung GE; Kim W; Kim YJ; Jang JJ; Lee HS
    J Viral Hepat; 2009 Jun; 16(6):444-52. PubMed ID: 19200133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
    Shin WG; Park SH; Jang MK; Hahn TH; Kim JB; Lee MS; Kim DJ; Jun SY; Park CK
    Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
    Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices.
    Kazemi F; Kettaneh A; N'kontchou G; Pinto E; Ganne-Carrie N; Trinchet JC; Beaugrand M
    J Hepatol; 2006 Aug; 45(2):230-5. PubMed ID: 16797100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis.
    Kim BK; Han KH; Park JY; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Kim DY
    Liver Int; 2010 Jul; 30(6):860-6. PubMed ID: 20492515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.
    Thabut D; Trabut JB; Massard J; Rudler M; Muntenau M; Messous D; Poynard T
    Liver Int; 2006 Apr; 26(3):271-8. PubMed ID: 16584387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of liver fibrosis in patients with chronic hepatitis B by serum markers.
    Pan JJ; Yang CF; Chu CJ; Chang FY; Lee SD
    Hepatogastroenterology; 2007; 54(77):1503-6. PubMed ID: 17708285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.
    Kim BK; Ahn SH; Han KH; Park JY; Han MS; Jo JH; Kim JK; Lee KS; Chon CY; Kim DY
    Digestion; 2012; 86(3):264-72. PubMed ID: 22986832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel panel of blood markers to assess the degree of liver fibrosis.
    Calès P; Oberti F; Michalak S; Hubert-Fouchard I; Rousselet MC; Konaté A; Gallois Y; Ternisien C; Chevailler A; Lunel F
    Hepatology; 2005 Dec; 42(6):1373-81. PubMed ID: 16317693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
    Halfon P; Bacq Y; De Muret A; Penaranda G; Bourliere M; Ouzan D; Tran A; Botta D; Renou C; Bréchot MC; Degott C; Paradis V
    J Hepatol; 2007 Mar; 46(3):395-402. PubMed ID: 17156890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C.
    Nahon P; Thabut G; Ziol M; Htar MT; Cesaro F; Barget N; Grando-Lemaire V; Ganne-Carrie N; Trinchet JC; Beaugrand M
    Am J Gastroenterol; 2006 Dec; 101(12):2744-51. PubMed ID: 17227522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.